Losing Weight RX vs. Hims Weight Loss

Back to Blog

The Quick Verdict

If you're comparing Hims weight loss to Losing Weight RX, the numbers tell a clear story. Losing Weight RX offers compounded semaglutide at a flat rate of $146 per month — all-inclusive, with no membership fees, no dose escalation surcharges, and free expedited shipping. Hims, on the other hand, charges a $149/mo membership fee on top of $149–$199/mo for brand-name medication, bringing the real monthly total to $298–$348.

The gap widens further when you consider what happened in early 2026: Hims abandoned compounded semaglutide entirely after Novo Nordisk, the pharmaceutical giant behind Wegovy and Ozempic, filed a lawsuit targeting compounding pharmacies and telehealth platforms. With the FDA simultaneously resolving the semaglutide shortage designation, Hims pivoted exclusively to brand-name medications — and passed the cost increase directly to its subscribers.

For patients who want the same active molecule at a fraction of the price, Losing Weight RX remains one of the most transparent and affordable options available in 2026. Let's break down exactly how these two platforms compare across every metric that matters.

---

Company Overview: Hims & Hers Health (NYSE: HIMS)

Hims & Hers Health, Inc. was founded in 2017 as a direct-to-consumer men's health platform, originally focused on hair loss treatments, erectile dysfunction, and skincare. The company went public on the NYSE under the ticker symbol HIMS and has grown into a publicly traded telehealth conglomerate with a market capitalization of approximately $4 billion and over 2 million active subscribers.

In 2023, Hims expanded aggressively into the weight loss market by offering compounded semaglutide through its telehealth platform. The pricing was initially competitive — around $199/month for compounded semaglutide — which attracted a massive wave of new subscribers seeking affordable alternatives to brand-name Wegovy (which retails for over $1,300/month without insurance).

However, the landscape shifted dramatically in early 2026. Novo Nordisk, the Danish pharmaceutical manufacturer of both Wegovy and Ozempic, filed a lawsuit against multiple telehealth platforms — including Hims — alleging trademark infringement and unauthorized marketing of compounded versions of its proprietary drugs. Around the same time, the FDA officially resolved the semaglutide drug shortage that had allowed compounding pharmacies to legally produce the medication under Section 503A of the Federal Food, Drug, and Cosmetic Act.

Facing legal pressure and regulatory uncertainty, Hims discontinued its compounded semaglutide program in March 2026 and pivoted to offering only brand-name Wegovy and Ozempic. This transition fundamentally changed the platform's pricing structure, and many subscribers reported feeling blindsided by the cost increase.

---

Company Overview: Losing Weight RX

Losing Weight RX is a telehealth platform that specializes exclusively in compounded GLP-1 medications for medical weight loss. Unlike large publicly traded corporations with diversified product lines, Losing Weight RX focuses on one thing: making evidence-based weight loss medications accessible and affordable.

The platform operates on a straightforward $146/mo flat-rate model for compounded semaglutide. This single price covers everything — the medication itself, the medical consultation with a licensed U.S. provider, ongoing clinical support, and free expedited shipping. There are no membership fees, no enrollment fees, no dose escalation charges, and no long-term contracts.

Patients begin by completing a 5-minute online health assessment. A board-certified physician reviews the submission within 24 hours, determines clinical eligibility, and — if appropriate — issues a prescription. The compounded medication is then prepared at a U.S.-licensed compounding pharmacy and cold-shipped directly to the patient's door.

For patients comparing Hims semaglutide price options, Losing Weight RX offers a significantly more transparent and budget-friendly alternative — especially in the post-compounding landscape that Hims has now exited.

---

Pricing Breakdown: What You Actually Pay

Pricing transparency is where the comparison between Losing Weight RX and Hims becomes most stark. Let's break down the real numbers — not the promotional headlines, but the actual ongoing monthly cost of treatment.

Hims Weight Loss: Real Monthly Cost

After discontinuing compounded semaglutide, Hims now charges two separate recurring fees:

• Membership Fee: $149/month (mandatory platform subscription)
• Brand-Name Medication: $149–$199/month (Wegovy or Ozempic, depending on dosage and availability)

This brings the real total monthly cost to $298–$348. Over a 12-month treatment period, that's $3,576 to $4,176.

Losing Weight RX: Real Monthly Cost

Losing Weight RX charges a single, all-inclusive price:

• Compounded Semaglutide: $146/month (flat rate, all doses)
• Includes: Medication + medical consultation + clinical support + free expedited shipping
• Membership fee: $0
• Dose escalation surcharge: $0

Over 12 months, the total cost is $1,752.

12-Month Cost Projection

The annual savings with Losing Weight RX range from $1,824 to $2,424 — enough to cover an entire additional year of treatment or more.

---

What Happened to Hims Compounded Semaglutide?

Understanding why Hims no longer offers compounded semaglutide is critical context for anyone searching for a Hims weight loss alternative.

For roughly two years (2023–early 2026), Hims was one of the largest telehealth providers of compounded semaglutide in the United States. The FDA had placed semaglutide on its drug shortage list, which legally permitted 503A and 503B compounding pharmacies to produce the medication. This created a window for telehealth platforms like Hims to offer semaglutide at a fraction of the brand-name retail price.

Two events in early 2026 closed that window for Hims specifically:

1. Novo Nordisk Lawsuit (January 2026): Novo Nordisk, the manufacturer of Wegovy and Ozempic, filed lawsuits against several telehealth companies — including Hims — alleging trademark infringement, misleading advertising, and unauthorized use of its drug formulations. The lawsuit specifically targeted platforms that marketed compounded semaglutide using brand-name references like "generic Ozempic" or "compounded Wegovy."
2. FDA Shortage Resolution (February 2026): The FDA officially removed semaglutide from its drug shortage list, signaling that brand-name supply had returned to normal. This removed the legal basis under which many compounding pharmacies had been producing the medication.

Facing both legal action and regulatory ambiguity, Hims made the corporate decision to discontinue all compounded semaglutide offerings in March 2026. The company pivoted to offering only FDA-approved brand-name Wegovy and Ozempic through its platform, but at significantly higher prices.

Losing Weight RX, by contrast, continues to operate within the compounding framework, sourcing from U.S.-licensed 503A compounding pharmacies that prepare custom formulations under the supervision of prescribing physicians. This allows Losing Weight RX to maintain its $146/mo flat-rate pricing while delivering the same active semaglutide molecule.

---

Medication Comparison: Compounded vs. Brand-Name

One of the most common questions from patients evaluating Hims vs. other weight loss platforms is whether compounded semaglutide is the same as brand-name Wegovy or Ozempic. Here's a clear breakdown:

What Hims Offers Now: Brand-Name Only

Since March 2026, Hims exclusively dispenses FDA-approved, brand-name semaglutide products — either Wegovy (indicated for chronic weight management) or Ozempic (indicated for type 2 diabetes, used off-label for weight loss). These are manufactured by Novo Nordisk in pre-filled injection pens at standardized dosages.

The advantage of brand-name medications is that they carry full FDA approval, meaning they have been evaluated for safety, efficacy, and manufacturing consistency through rigorous clinical trials. The disadvantage? They cost significantly more — even through Hims' telehealth platform.

What Losing Weight RX Offers: Compounded Semaglutide

Losing Weight RX provides compounded semaglutide — the same active molecule used in Wegovy and Ozempic — but custom-prepared by U.S.-licensed compounding pharmacies. The medication is delivered as an injectable solution in multi-dose vials, allowing providers to customize dosages precisely to each patient's titration schedule.

Compounded medications are not FDA-approved products. They are, however, legally prepared under federal and state compounding regulations and dispensed pursuant to valid prescriptions from licensed physicians. The active pharmaceutical ingredient (semaglutide) is identical; the difference lies in the manufacturing process, packaging, and regulatory pathway.

For a deeper dive into safety and regulation, read our full guide: Is Compounded Semaglutide Safe?

---

Side-by-Side Comparison Table

The following table presents a comprehensive feature-by-feature comparison between Losing Weight RX and Hims' weight loss program as of May 2026. For similar comparisons with other popular telehealth providers, see our Cheapest Semaglutide Online, Losing Weight RX vs. Calibrate, and Losing Weight RX vs. Henry Meds reviews.

---

Customer Experience: What Users Are Saying

Hims: Polished App, Mixed Reviews

There's no denying that Hims has a slick, well-designed mobile application and a strong brand presence. The platform invested heavily in user experience design and celebrity endorsements, creating a premium feel that appeals to first-time telehealth users.

However, beneath the polished surface, a growing number of users have voiced frustration on platforms like Reddit, Trustpilot, and the Better Business Bureau. The most common complaints include:

• Billing Transparency: Multiple users report being surprised by the total cost after the first-month promotional period ends. The $39 intro offer is prominently displayed, while the ongoing $298–$348/mo cost requires careful reading of the fine print.
• Auto-Renewal Charges: Hims operates on an auto-renewing subscription model. Several users have reported being charged for months they didn't intend to continue, with some describing the practice as "catfishing" on Reddit threads.
• Cancellation Difficulty: A recurring theme in online reviews is the difficulty of canceling a Hims weight loss subscription. Users report being directed through multiple steps, encountering retention offers, and in some cases, being billed after submitting a cancellation request. For anyone searching "cancel Hims weight loss," this is a real and documented concern.
• Post-Compounding Price Shock: Users who initially subscribed for compounded semaglutide at a lower price point have reported feeling blindsided when Hims transitioned to brand-name only in March 2026, effectively doubling their monthly cost.

Losing Weight RX: Straightforward and Transparent

Losing Weight RX operates on a fundamentally different service model. There is no membership tier, no promotional pricing that expires, and no auto-renewing subscription lock-in. The $146/mo price is the price — from your first month through your maintenance phase, regardless of dosage level.

Patients interact primarily through a streamlined patient portal. The onboarding process (5-minute health assessment → 24-hour provider review → prescription → cold-shipped delivery) is designed to be frictionless and fully asynchronous. There are no mandatory video calls, no app downloads required, and no upsell sequences.

Cancellation is handled directly through the patient portal — no phone calls to retention departments, no multi-step processes, and no penalty fees. You can pause, modify, or cancel your treatment at any time.

---

Who Should Choose Hims?

In the interest of providing a balanced comparison, there are scenarios where Hims may be the right choice:

• Brand-name preference: If you specifically want FDA-approved, brand-name Wegovy or Ozempic and are willing to pay a premium for that assurance, Hims provides a convenient telehealth channel to obtain it.
• Existing Hims subscriber: If you're already using Hims for other health products (hair loss, skincare, mental health) and want the convenience of managing everything through a single platform, the integrated ecosystem may have value.
• Insurance reimbursement: In some cases, brand-name medications prescribed through Hims may qualify for partial insurance reimbursement, which could offset the higher cost. (Check with your specific insurance provider.)

Who Should Choose Losing Weight RX?

Losing Weight RX is the clear choice for patients who prioritize:

• Affordability: At $146/mo, Losing Weight RX costs less than half of what Hims charges for the same active molecule. Over a year, the savings are substantial — $1,824 to $2,424.
• Pricing transparency: No membership fees, no promotional gimmicks, no dose escalation charges. One price, every month.
• Flexibility: Month-to-month treatment with no contracts and easy cancellation. You're never locked in.
• Speed: 24-hour provider review and free expedited shipping means you can start treatment quickly without scheduling video appointments.
• The same active molecule: Compounded semaglutide delivers the identical GLP-1 receptor agonist as brand-name Wegovy and Ozempic, prepared by U.S.-licensed pharmacies.

---

Frequently Asked Questions (FAQs)

---

Final Recommendation: The Clear Value Leader

When comparing Losing Weight RX and Hims weight loss in 2026, the decision comes down to a simple question: do you want to pay more than twice as much for the same active molecule?

Hims has built a recognizable brand, but its pivot to brand-name only medication in March 2026 — combined with a mandatory $149/month membership fee — has pushed its total cost to $298–$348/month. For many patients, that price point is simply unsustainable for a treatment that requires months or years of consistent use.

Losing Weight RX offers the same active semaglutide molecule at $146/month flat. No membership fees, no promotional bait-and-switch, no dose escalation charges, and no contracts. The savings are real: $1,824–$2,424 per year.

If you're currently on Hims and considering a switch, or if you're just starting your weight loss journey and want the most honest, transparent pricing available, Losing Weight RX is the clear value leader in 2026.

---